Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of EIF4G2 protein | increases expression | 18491231
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of EIF4G2 mRNA | affects expression | 21346803
|
C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in decreased expression of EIF4G2 mRNA | decreases expression | 12958071
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in increased expression of EIF4G2 mRNA | increases expression | 18648102
|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased cleavage of EIF4G2 protein | increases cleavage | 18491231
|
D001554 |
Benzene |
Benzene results in increased expression of EIF4G2 mRNA | increases expression | 15878777
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of EIF4G2 protein | increases expression | 18491231
|
D004121 |
Dimethyl Sulfoxide |
Dimethyl Sulfoxide results in increased expression of EIF4G2 protein | increases expression | 18491231
|
D004958 |
Estradiol |
Estradiol affects the expression of EIF4G2 mRNA | affects expression | 15598610
|
C008493 |
methylselenic acid |
methylselenic acid results in decreased expression of EIF4G2 mRNA | decreases expression | 12517777
|
C487081 |
PXD101 |
PXD101 results in decreased expression of EIF4G2 mRNA | decreases expression | 19606018
|
C410733 |
scriptaid |
scriptaid affects the expression of EIF4G2 mRNA | affects expression | 18813790
|
D020123 |
Sirolimus |
Sirolimus results in increased expression of EIF4G2 protein | increases expression | 18491231
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of EIF4G2 mRNA | decreases expression | 20308225
|
D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of EIF4G2 mRNA | increases expression | 18175754
|
C517826 |
tetrabrominated diphenyl ether 47 |
tetrabrominated diphenyl ether 47 results in increased expression of EIF4G2 mRNA | increases expression | 20056577
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of EIF4G2 mRNA | increases expression | 19465110
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in increased expression of EIF4G2 protein | increases expression | 18491231
|
D014212 |
Tretinoin |
PDCD4 protein promotes the reaction [Tretinoin results in increased expression of EIF4G2 protein] | increases expression|increases reaction | 17259349
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of and results in increased localization of EIF4G2 protein | increases expression|increases localization | 18491231
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of EIF4G2 mRNA | increases expression | 18491231
|
C012589 |
trichostatin A |
trichostatin A results in decreased expression of EIF4G2 mRNA | decreases expression | 19606018
|
C025643 |
vinclozolin |
vinclozolin affects the expression of EIF4G2 mRNA | affects expression | 19015723
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.74 | 15322242 14514962 11752688 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
4.30 | 19825857 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.30 | 11473722 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
2.69 | 3712494 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.27 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.59 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.80 | 17306315 16712894 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.53 | 15955085 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.85 | 11748828 |
MESH:D000741 |
Anemia, Aplastic |
|
Benzene |
4.28 | 14761424 11369114 17661222 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.55 | 19015723 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.01 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.24 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.31 | 16456186 |
MESH:D001321 |
Autistic Disorder |
|
Sirolimus |
3.01 | 21115397 |
MESH:D001321 |
Autistic Disorder |
|
tetrabrominated diphenyl ether 47 |
3.01 | 19211157 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.29 | 16935849 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.91 | 1440618 11289319 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
14.75 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
14.75 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
14.75 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.69 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.69 | 15746008 |
MESH:D001855 |
Bone Marrow Diseases |
|
Benzene |
5.12 | 16183116 |
MESH:D001943 |
Breast Neoplasms |
|
Benzene |
2.31 | 11921183 17162533 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
2.31 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.31 | 17289903 17261762 12948864 14630087 19861407 17018787 18497071 16675129 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.31 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.31 | 16873071 16443354 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.48 | 16813970 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.22 | 11589617 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.35 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.71 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.05 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
13.83 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
13.83 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
13.83 | 14691202 11135700 16217749 15553829 15073043 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
13.83 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Sirolimus |
13.83 | 19335982 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
13.83 | 15276417 16507464 17306315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
13.83 | 1917145 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.77 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.62 | 7296757 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.02 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
14.04 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Sirolimus |
14.04 | 19435901 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
14.04 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
14.04 | 18922899 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
14.04 | 16096774 16051514 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.31 | 18850075 18670907 16120746 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.03 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
15.40 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
15.40 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
15.40 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
15.40 | 19524636 20056578 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.48 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.07 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
3.06 | 9022650 19486331 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.05 | 16461808 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
4.64 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.61 | 8697196 12621046 16354765 15340226 15668235 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.61 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.60 | 17035595 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
1.86 | 20501625 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.96 | 14669216 17141729 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.08 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
5.33 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Benzene |
5.33 | 15643154 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
5.33 | 10048152 15322242 20055451 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
5.33 | 9224671 8800419 9125849 16925845 9664655 10589399 9211117 17551590 14991402 9142499 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.23 | 14966744 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
3.91 | 18551238 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.99 | 15213294 |
MESH:D003872 |
Dermatitis |
|
Benzene |
4.66 | 15902427 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.70 | 18759878 11906362 8156756 2524372 12868966 11298694 8970840 14531868 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.39 | 2952479 3621924 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.68 | 16285004 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.64 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.32 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
8.70 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
8.70 | 18692083 9653073 9328219 1440618 18289764 16192314 11289319 18648102 9022650 7440962 6482804 8291058 6679447 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
8.70 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
8.70 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.68 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.62 | 11000095 12711302 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
6.62 | 9599246 15177302 7812673 16716910 8273558 11698051 8113982 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.59 | 18230668 16714409 15322242 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.59 | 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
3.83 | 15138306 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
trichostatin A |
5.53 | 19294695 |
MESH:D018159 |
Endolymphatic Hydrops |
|
Dimethyl Sulfoxide |
6.46 | 20641076 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
7.17 | 19148513 11473722 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
7.17 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.92 | 10568697 9294722 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
4.38 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
4.38 | 12903497 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.56 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.56 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
3.19 | 15073043 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.35 | 11858732 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.91 | 6705139 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.26 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
8.26 | 17994277 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.15 | 16904648 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.83 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.19 | 16417039 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.57 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
7.18 | 17312396 |
MESH:D005909 |
Glioblastoma |
|
trichostatin A |
7.18 | 18801729 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.93 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.49 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Sirolimus |
7.94 | 19435901 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
7.94 | 16096774 |
MESH:D034381 |
Hearing Loss |
|
Dimethyl Sulfoxide |
5.07 | 20641076 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.05 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.34 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.34 | 9664655 14991402 |
MESH:D006402 |
Hematologic Diseases |
|
Benzene |
4.55 | 16183116 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.23 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.41 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.78 | 15340226 12621046 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.93 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.06 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.65 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.94 | 8697196 16354765 16959395 18606429 15340226 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.12 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.46 | 16778211 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.83 | 15034207 |
MESH:D006973 |
Hypertension |
|
Benzene |
5.17 | 17940673 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.17 | 18670907 18850075 |
MESH:D006984 |
Hypertrophy |
|
Sirolimus |
5.13 | 19211884 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.60 | 12646999 15346721 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
6.60 | 16467254 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.97 | 12878042 12200463 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
4.97 | 7562506 7812673 11698051 8273558 15177302 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.19 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
7.19 | 14714311 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.66 | 17994277 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.91 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.59 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.59 | 15992940 17551590 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
5.90 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
5.90 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
11.87 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
11.87 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
11.87 | 15610895 |
MESH:D007938 |
Leukemia |
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
14.58 | 12970779 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
14.58 | 15070760 |
MESH:D007938 |
Leukemia |
|
Benzene |
14.58 | 15935818 14694614 17119257 18335105 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
14.58 | 17143497 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
3.69 | 12560223 17077332 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.20 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.35 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
15.45 | 19077051 |
MESH:D007951 |
Leukemia, Myeloid |
|
Benzene |
15.45 | 17506065 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
15.45 | 16482212 19285840 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
8.65 | 16467208 16968895 19850784 17050201 20471514 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Benzene |
8.65 | 19478238 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
8.65 | 16294345 19850784 17596541 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
trichostatin A |
8.65 | 18206229 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
7.39 | 16966277 17712046 12679006 19075265 17869043 16112521 15336539 11468182 15213294 19642359 16330433 16823087 16891316 17107899 15622746 12712474 17217047 15748426 12018890 9834237 19225113 16331271 11161223 19035177 17649720 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
7.39 | 17217047 16331271 19035177 19225113 16140955 17506722 16823087 15748426 17294898 17368321 17649720 16788101 17339181 19075265 16891316 12679006 9834237 16766008 19642359 17301526 17712046 19029980 17361223 16935935 17107899 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.24 | 16882451 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.62 | 16417039 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.23 | 9224671 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.13 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dimethyl Sulfoxide |
6.63 | 11682029 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
6.63 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Sirolimus |
6.63 | 17050028 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
6.63 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
6.63 | 16248980 18397230 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
10.36 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
10.36 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
10.36 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.36 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
17.92 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
17.92 | 598648 1399818 6587162 3712494 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
17.92 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Benzene |
17.92 | 12562636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
17.92 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.26 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.10 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Benzene |
4.70 | 14698565 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
6.47 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Benzene |
6.47 | 12562636 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
6.47 | 19931552 17306315 15276417 16712894 17077188 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
6.47 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
6.47 | 11807781 |
MESH:D008223 |
Lymphoma |
|
Benzene |
3.66 | 17584886 17119257 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
3.95 | 14737004 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Benzene |
4.33 | 12562636 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Benzene |
9.72 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
9.72 | 11408345 17203775 11807958 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
9.72 | 8985016 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.38 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.74 | 17453147 |
MESH:D008545 |
Melanoma |
|
Sirolimus |
7.23 | 19282848 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
7.23 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
7.23 | 16752155 |
MESH:D008545 |
Melanoma |
|
trichostatin A |
7.23 | 16505122 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.32 | 16940565 |
MESH:D009062 |
Mouth Neoplasms |
|
Sirolimus |
4.62 | 19435901 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
11.82 | 19549372 19417148 11468182 14977855 15949261 |
MESH:D009101 |
Multiple Myeloma |
|
Benzene |
11.82 | 17119195 |
MESH:D009101 |
Multiple Myeloma |
|
trichostatin A |
11.82 | 18172295 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.57 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
7.18 | 16105982 16882451 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.18 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.93 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.19 | 16810080 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.75 | 18551238 7678174 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.85 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
2.43 | 3581430 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
4.93 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
4.93 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.56 | 20056578 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.62 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
15.71 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
15.71 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
15.71 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
22.00 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
22.00 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Benzene |
22.00 | 15643154 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
22.00 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
22.00 | 9142499 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
14.60 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
14.60 | 6482804 4026338 |
MESH:D009784 |
Occupational Diseases |
|
Benzene |
14.60 | 17178637 15727169 15576619 16737584 17119257 15913788 17479406 15612468 15935809 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.91 | 3988306 |
MESH:D010051 |
Ovarian Neoplasms |
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
22.43 | 16211241 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
22.43 | 16624393 19769630 12452020 |
MESH:D010051 |
Ovarian Neoplasms |
|
Benzene |
22.43 | 12562636 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
22.43 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
22.43 | 17306315 15276417 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
22.43 | 16936753 |
MESH:D010051 |
Ovarian Neoplasms |
|
trichostatin A |
22.43 | 19331143 |
MESH:D010146 |
Pain |
|
Tretinoin |
2.81 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
12.08 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
12.08 | 15976015 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
12.08 | 15976015 |
MESH:D010190 |
Pancreatic Neoplasms |
|
trichostatin A |
12.08 | 19294695 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
9.03 | 7296757 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
9.03 | 8330346 12065085 18922899 18404319 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.06 | 19927285 |
MESH:D010300 |
Parkinson Disease |
|
Sirolimus |
3.70 | 19682553 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.14 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.36 | 6228378 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.45 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.13 | 11118676 11896295 11399792 11222880 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
9.13 | 19015723 18220299 18042343 |
MESH:D055728 |
Primary Myelofibrosis |
|
trichostatin A |
5.14 | 17616702 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.83 | 18220299 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.67 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.78 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
2.09 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
2.09 | 15754350 12479363 18247401 16644109 16289102 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.09 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
methylselenic acid |
2.09 | 16205645 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.09 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
2.09 | 18760546 |
MESH:D011471 |
Prostatic Neoplasms |
|
trichostatin A |
2.09 | 19789329 18798265 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.83 | 18629315 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.50 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.68 | 16723453 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.73 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.29 | 3692021 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
3.99 | 16283617 16116481 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
3.85 | 16646077 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.46 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
13.17 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
13.17 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
13.17 | 18404319 12065085 8330346 11807781 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
13.17 | 16467112 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.71 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
3.40 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzene |
3.40 | 12562636 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
3.40 | 17261132 |
MESH:D013953 |
Thymus Neoplasms |
|
Benzene |
4.85 | 10850423 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.80 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
11.47 | 1399818 3712494 6587162 6582329 7505956 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
11.47 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
11.47 | 17045167 16026305 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.58 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.69 | 16051514 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.85 | 15213294 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.16 | 16040207 |
MESH:D014402 |
Tuberous Sclerosis |
|
Sirolimus |
5.46 | 21115397 18495876 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
11.58 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
11.58 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
11.58 | 12973940 12845720 11780464 20435036 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
11.58 | 17306315 11723127 16452187 16712894 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.21 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
9.08 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
9.08 | 16129372 |
MESH:D014594 |
Uterine Neoplasms |
|
Benzene |
4.23 | 12562636 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.50 | 16752155 |
MESH:D014605 |
Uveitis |
|
Sirolimus |
5.53 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.32 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.49 | 12125929 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.95 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.14 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.87 | 16287080 |